Patient-reported outcomes in patients with paroxysmal nocturnal hemoglobinuria treated with crovalimab and approved C5 inhibitors in the phase III COMMODORE 2 and 1 studies

Journal Name
Annals of Hematology
Primary Author
Panse J
Author(s)
Panse J, Han B, Cermak J, Gonzalez Fernandez FA, Gotoh A, Kulasekararaj AG, Kyselova O, Sahin F, Scheinberg P, Schrezenmeier H, Straetmans N, Ueda Y, Chang AC, Gentile B, Stefani J, Uguen M, Röth A
Original Publication Date
Full Article on PubMed
https://www.ncbi.nlm.nih.gov/pubmed/40515823
Diseases
Paroxysmal Nocturnal Hemoglobinuria (PNH)

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.

We Recommend

For Research